ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,193.60
0.54%
Dow Jones
43,870.35
1.06%
Gold vs US Dollar
2,695.355
0.98%
Brent Oil
73.925
-0.01%
Bitcoin
98,651.63
0.14%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Silexion Therapeutics Corporation (SLXNW)

  7. Silexion Therapeutics Corporation (SLXNW) News

Silexion Therapeutics (SLXNW)

Silexion Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SLXNW
DateTimeSourceHeadlineSymbolCompany
20/11/202411:15Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:SLXNWSilexion Therapeutics Corporation
19/11/202421:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SLXNWSilexion Therapeutics Corporation
19/11/202421:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SLXNWSilexion Therapeutics Corporation
19/11/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
14/11/202414:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
14/11/202413:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLXNWSilexion Therapeutics Corporation
13/11/202421:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLXNWSilexion Therapeutics Corporation
01/11/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
31/10/202421:24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SLXNWSilexion Therapeutics Corporation
22/10/202413:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SLXNWSilexion Therapeutics Corporation
17/10/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLXNWSilexion Therapeutics Corporation
16/10/202413:32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SLXNWSilexion Therapeutics Corporation
10/10/202421:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SLXNWSilexion Therapeutics Corporation
09/10/202410:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SLXNWSilexion Therapeutics Corporation
01/10/202410:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
24/09/202411:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
19/09/202420:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SLXNWSilexion Therapeutics Corporation
19/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
18/09/202420:32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SLXNWSilexion Therapeutics Corporation
18/09/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLXNWSilexion Therapeutics Corporation
09/09/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLXNWSilexion Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:SLXNW

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
VAST
Vast Resources
LSE
HEMO
Hemogenyx Pharmaceuticals
LSE
GGP
Greatland Gold
LSE
NFDS
Northern Foods
LSE
GDR
Genedrive
LSE
GEX
Georgina Energy
LSE
SYME
Supply@me Capital
LSE
TERN
Tern
LSE
UPS
LSE
POS
Plexus
LSE
ALTN
Altyngold
LSE
BARC
Barclays
LSE
ITM
Itm Power
LSE
NEXN
Nexxen
LSE
CYAN
Cyanconnode
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06